Europe Genitourinary Drugs Market Report 2016

Europe Genitourinary Drugs Market Report 2016

1 Genitourinary Drugs Overview

1.1 Product Overview and Scope of Genitourinary Drugs

1.2 Classification of Genitourinary Drugs

1.2.1 Sex Hormones

1.2.2 Urologicals

1.2.3 Genitourinary Anti-Infectives

1.2.4 Gynaecologicals

1.3 Application of Genitourinary Drugs

1.3.1 Genitourinary Cancer

1.3.2 Bladder Cancer

1.3.3 Cervical Cancer

1.3.4 Kidney/Renal Cancer

1.3.5 Ovarian Cancer

1.3.6 Prostate Cancer

1.4 Genitourinary Drugs Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Genitourinary Drugs (2011-2021)

1.5.1 Europe Genitourinary Drugs Sales and Growth Rate (2011-2021)

1.5.2 Europe Genitourinary Drugs Revenue and Growth Rate (2011-2021)

2 Europe Genitourinary Drugs by Manufacturers, Type and Application

2.1 Europe Genitourinary Drugs Market Competition by Manufacturers

2.1.1 Europe Genitourinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Genitourinary Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Genitourinary Drugs (Volume and Value) by Type

2.2.1 Europe Genitourinary Drugs Sales and Market Share by Type (2011-2016)

2.2.2 Europe Genitourinary Drugs Revenue and Market Share by Type (2011-2016)

2.3 Europe Genitourinary Drugs (Volume and Value) by Countries

2.3.1 Europe Genitourinary Drugs Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Genitourinary Drugs Revenue and Market Share by Countries (2011-2016)

2.4 Europe Genitourinary Drugs (Volume) by Application

3 Germany Genitourinary Drugs (Volume, Value and Sales Price)

3.1 Germany Genitourinary Drugs Sales and Value (2011-2016)

3.1.1 Germany Genitourinary Drugs Sales and Growth Rate (2011-2016)

3.1.2 Germany Genitourinary Drugs Revenue and Growth Rate (2011-2016)

3.1.3 Germany Genitourinary Drugs Sales Price Trend (2011-2016)

3.2 Germany Genitourinary Drugs Sales and Market Share by Manufacturers

3.3 Germany Genitourinary Drugs Sales and Market Share by Type

3.4 Germany Genitourinary Drugs Sales and Market Share by Application

4 France Genitourinary Drugs (Volume, Value and Sales Price)

4.1 France Genitourinary Drugs Sales and Value (2011-2016)

4.1.1 France Genitourinary Drugs Sales and Growth Rate (2011-2016)

4.1.2 France Genitourinary Drugs Revenue and Growth Rate (2011-2016)

4.1.4 France Genitourinary Drugs Sales Price Trend (2011-2016)

4.2 France Genitourinary Drugs Sales and Market Share by Manufacturers

4.3 France Genitourinary Drugs Sales and Market Share by Type

4.4 France Genitourinary Drugs Sales and Market Share by Application

5 UK Genitourinary Drugs (Volume, Value and Sales Price)

5.1 UK Genitourinary Drugs Sales and Value (2011-2016)

5.1.1 UK Genitourinary Drugs Sales and Growth Rate (2011-2016)

5.1.2 UK Genitourinary Drugs Revenue and Growth Rate (2011-2016)

5.1.5 UK Genitourinary Drugs Sales Price Trend (2011-2016)

5.2 UK Genitourinary Drugs Sales and Market Share by Manufacturers

5.3 UK Genitourinary Drugs Sales and Market Share by Type

5.4 UK Genitourinary Drugs Sales and Market Share by Application

6 Russia Genitourinary Drugs (Volume, Value and Sales Price)

6.1 Russia Genitourinary Drugs Sales and Value (2011-2016)

6.1.1 Russia Genitourinary Drugs Sales and Growth Rate (2011-2016)

6.1.2 Russia Genitourinary Drugs Revenue and Growth Rate (2011-2016)

6.1.6 Russia Genitourinary Drugs Sales Price Trend (2011-2016)

6.2 Russia Genitourinary Drugs Sales and Market Share by Manufacturers

6.3 Russia Genitourinary Drugs Sales and Market Share by Type

6.4 Russia Genitourinary Drugs Sales and Market Share by Application

7 Italy Genitourinary Drugs (Volume, Value and Sales Price)

7.1 Italy Genitourinary Drugs Sales and Value (2011-2016)

7.1.1 Italy Genitourinary Drugs Sales and Growth Rate (2011-2016)

7.1.2 Italy Genitourinary Drugs Revenue and Growth Rate (2011-2016)

7.1.7 Italy Genitourinary Drugs Sales Price Trend (2011-2016)

7.2 Italy Genitourinary Drugs Sales and Market Share by Manufacturers

7.3 Italy Genitourinary Drugs Sales and Market Share by Type

7.4 Italy Genitourinary Drugs Sales and Market Share by Application

8 Spain Genitourinary Drugs (Volume, Value and Sales Price)

8.1 Spain Genitourinary Drugs Sales and Value (2011-2016)

8.1.1 Spain Genitourinary Drugs Sales and Growth Rate (2011-2016)

8.1.2 Spain Genitourinary Drugs Revenue and Growth Rate (2011-2016)

8.1.8 Spain Genitourinary Drugs Sales Price Trend (2011-2016)

8.2 Spain Genitourinary Drugs Sales and Market Share by Manufacturers

8.3 Spain Genitourinary Drugs Sales and Market Share by Type

8.4 Spain Genitourinary Drugs Sales and Market Share by Application

9 Benelux Genitourinary Drugs (Volume, Value and Sales Price)

9.1 Benelux Genitourinary Drugs Sales and Value (2011-2016)

9.1.1 Benelux Genitourinary Drugs Sales and Growth Rate (2011-2016)

9.1.2 Benelux Genitourinary Drugs Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Genitourinary Drugs Sales Price Trend (2011-2016)

9.2 Benelux Genitourinary Drugs Sales and Market Share by Manufacturers

9.3 Benelux Genitourinary Drugs Sales and Market Share by Type

9.4 Benelux Genitourinary Drugs Sales and Market Share by Application

10 Europe Genitourinary Drugs Manufacturers Analysis

10.1 Astellas

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Genitourinary Drugs Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Pfizer

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Genitourinary Drugs Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 GlaxoSmithKline

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Genitourinary Drugs Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Eli Lilly

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Genitourinary Drugs Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Bayer AG

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Genitourinary Drugs Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Merck

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Genitourinary Drugs Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Abbott Laboratories

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Genitourinary Drugs Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Bristol-Myers Squibb

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Genitourinary Drugs Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Genentech

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Genitourinary Drugs Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Roche

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Genitourinary Drugs Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Amgen

10.12 Botex

11 Genitourinary Drugs Manufacturing Cost Analysis

11.1 Genitourinary Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Genitourinary Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Genitourinary Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Genitourinary Drugs Market Forecast (2016-2021)

14.1 Germany Genitourinary Drugs Sales Forecast (2016-2021)

14.2 France Genitourinary Drugs Sales Forecast (2016-2021)

14.3 UK Genitourinary Drugs Sales Forecast (2016-2021)

14.4 Russia Genitourinary Drugs Sales Forecast (2016-2021)

14.5 Italy Genitourinary Drugs Sales Forecast (2016-2021)

14.6 Spain Genitourinary Drugs Sales Forecast (2016-2021)

14.7 Benelux Genitourinary Drugs Sales Forecast (2016-2021)

14.8 Europe Genitourinary Drugs Sales Forecast by Type (2016-2021)

14.9 Europe Genitourinary Drugs Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Genitourinary Drugs

Table Classification of Genitourinary Drugs

Figure Europe Sales Market Share of Genitourinary Drugs by Type in 2015

Figure Sex Hormones Picture

Figure Urologicals Picture

Figure Genitourinary Anti-Infectives Picture

Figure Gynaecologicals Picture

Table Application of Genitourinary Drugs

Figure Europe Sales Market Share of Genitourinary Drugs by Application in 2015

Figure Genitourinary Cancer Examples

Figure Bladder Cancer Examples

Figure Cervical Cancer Examples

Figure Kidney/Renal Cancer Examples

Figure Ovarian Cancer Examples

Figure Prostate Cancer Examples

Figure Germany Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure France Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure UK Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure Benelux Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Genitourinary Drugs Sales and Growth Rate (2011-2021)

Figure Europe Genitourinary Drugs Revenue and Growth Rate (2011-2021)

Table Europe Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Genitourinary Drugs Sales Share by Manufacturers

Figure 2016 Genitourinary Drugs Sales Share by Manufacturers

Table Europe Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Genitourinary Drugs Revenue Share by Manufacturers

Table 2016 Europe Genitourinary Drugs Revenue Share by Manufacturers

Table Europe Genitourinary Drugs Sales and Market Share by Type (2011-2016)

Table Europe Genitourinary Drugs Sales Share by Type (2011-2016)

Figure Sales Market Share of Genitourinary Drugs by Type (2011-2016)

Figure Europe Genitourinary Drugs Sales Growth Rate by Type (2011-2016)

Table Europe Genitourinary Drugs Revenue and Market Share by Type (2011-2016)

Table Europe Genitourinary Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Genitourinary Drugs by Type (2011-2016)

Figure Europe Genitourinary Drugs Revenue Growth Rate by Type (2011-2016)

Table Europe Genitourinary Drugs Sales and Market Share by Countries (2011-2016)

Table Europe Genitourinary Drugs Sales Share by Countries (2011-2016)

Figure Sales Market Share of Genitourinary Drugs by Countries (2011-2016)

Table Europe Genitourinary Drugs Revenue and Market Share by Countries (2011-2016)

Table Europe Genitourinary Drugs Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Genitourinary Drugs by Countries (2011-2016)

Table Europe Genitourinary Drugs Sales and Market Share by Application (2011-2016)

Table Europe Genitourinary Drugs Sales Share by Application (2011-2016)

Figure Sales Market Share of Genitourinary Drugs by Application (2011-2016)

Figure Germany Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure Germany Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure Germany Genitourinary Drugs Sales Price Trend (2011-2016)

Table Germany Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Genitourinary Drugs Sales by Type (2015 and 2016)

Table Germany Genitourinary Drugs Market Share by Type (2015 and 2016)

Table Germany Genitourinary Drugs Sales by Application (2015 and 2016)

Table Germany Genitourinary Drugs Market Share by Application (2015 and 2016)

Figure France Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure France Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure France Genitourinary Drugs Sales Price Trend (2011-2016)

Table France Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table France Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table France Genitourinary Drugs Sales by Type (2015 and 2016)

Table France Genitourinary Drugs Market Share by Type (2015 and 2016)

Table France Genitourinary Drugs Sales by Application (2015 and 2016)

Table France Genitourinary Drugs Market Share by Application (2015 and 2016)

Figure UK Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure UK Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure UK Genitourinary Drugs Sales Price Trend (2011-2016)

Table UK Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table UK Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Genitourinary Drugs Sales by Type (2015 and 2016)

Table UK Genitourinary Drugs Market Share by Type (2015 and 2016)

Table UK Genitourinary Drugs Sales by Application (2015 and 2016)

Table UK Genitourinary Drugs Market Share by Application (2015 and 2016)

Figure Russia Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure Russia Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure Russia Genitourinary Drugs Sales Price Trend (2011-2016)

Table Russia Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Genitourinary Drugs Sales by Type (2015 and 2016)

Table Russia Genitourinary Drugs Market Share by Type (2015 and 2016)

Table Russia Genitourinary Drugs Sales by Application (2015 and 2016)

Table Russia Genitourinary Drugs Market Share by Application (2015 and 2016)

Figure Italy Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure Italy Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure Italy Genitourinary Drugs Sales Price Trend (2011-2016)

Table Italy Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Genitourinary Drugs Sales by Type (2015 and 2016)

Table Italy Genitourinary Drugs Market Share by Type (2015 and 2016)

Table Italy Genitourinary Drugs Sales by Application (2015 and 2016)

Table Italy Genitourinary Drugs Market Share by Application (2015 and 2016)

Figure Spain Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure Spain Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure Spain Genitourinary Drugs Sales Price Trend (2011-2016)

Table Spain Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Genitourinary Drugs Sales by Type (2015 and 2016)

Table Spain Genitourinary Drugs Market Share by Type (2015 and 2016)

Table Spain Genitourinary Drugs Sales by Application (2015 and 2016)

Table Spain Genitourinary Drugs Market Share by Application (2015 and 2016)

Figure Benelux Genitourinary Drugs Sales and Growth Rate (2011-2016)

Figure Benelux Genitourinary Drugs Revenue and Growth Rate (2011-2016)

Figure Benelux Genitourinary Drugs Sales Price Trend (2011-2016)

Table Benelux Genitourinary Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Genitourinary Drugs Sales by Type (2015 and 2016)

Table Benelux Genitourinary Drugs Market Share by Type (2015 and 2016)

Table Benelux Genitourinary Drugs Sales by Application (2015 and 2016)

Table Benelux Genitourinary Drugs Market Share by Application (2015 and 2016)

Table Genitourinary Drugs Basic Information List

Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Astellas Genitourinary Drugs Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Genitourinary Drugs Sales Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Genitourinary Drugs Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Genitourinary Drugs Sales Market Share (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer AG Genitourinary Drugs Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Genitourinary Drugs Sales Market Share (2011-2016)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Laboratories Genitourinary Drugs Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Genitourinary Drugs Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Genitourinary Drugs Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Genitourinary Drugs Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Genitourinary Drugs Sales Market Share (2011-2016)

Table Botex Basic Information List

Table Botex Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Botex Genitourinary Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Genitourinary Drugs

Figure Manufacturing Process Analysis of Genitourinary Drugs

Figure Genitourinary Drugs Industrial Chain Analysis

Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015

Table Major Buyers of Genitourinary Drugs

Table Distributors/Traders List

Figure Germany Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Germany Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure France Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure France Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure UK Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure UK Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Russia Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Italy Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Spain Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Genitourinary Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)

Table Europe Genitourinary Drugs Sales Forecast by Type (2016-2021)

Table Europe Genitourinary Drugs Sales Forecast by Application (2016-2021)